{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 2 Study Evaluating the Efficacy of Anti-CD38 antibody in Combination with KRAS vaccine and Anti-PD-1 Antibody in Subjects with Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-2-study-evaluating-the-efficacy-of-anti-cd38-antibody-in-combination-with-kras-vaccine-and-anti-pd-1-antibody-in-subjects-with-pancreatic-ductal-adenocarcinoma-and-refractory-non-small-cell-lu\/#breadcrumbitem"}]}